Epsilon M&A Deal Report - European veterinary business of ALK-Abelló
Transaction Multiples for the Valuation of Private Companies
Private Group led by Fidelio Capital / European veterinary business of ALK-Abelló
No EMAT :
87710
Announced Date :
18/12/2015
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Fidelio Capital
Target :
European veterinary business of ALK-Abelló
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
ALK’s veterinary business specialises in the development, manufacturing and marketing of immunotherapy products for veterinary use . > Activities were previously an integrated part of ALK's...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 08/06/2017 | Private Group Led by Intermediate Capital Group and Sagesse Retraite Sante | DomusVi Group | France | *** | 87458 |
| 23/06/2017 | Animalcare Group | Ecuphar | Belgium | *** | 87154 |
Source: Epsilon Research / EMAT
